Anisia Corona -  Founder and CEO of Scope

Anisia Corona - Founder and CEO of Scope

Tuesday Mentor, Thursday Speaker

Anisia is an executive leader and change agent for the health and wellness industry with 22 years in healthcare – 11 yrs experience in direct patient care and 11 yrs building and improving the quality and technical utility of services.

Anisia has two undergrad degrees in the sciences from San Francisco University. She pivoted away from medical school and attended public health and business grad school at The University of Queensland in Australia. She is currently working on completing an MBA at Quantic School of Business and Technology to improve her business and technology acumen to bridge and augment her extensive knowledge in healthcare. She has been an Entrepreneur in Health 2.0 San Francisco’s 1st digital health pre-accelerator, and is currently with ASU’s venture development program, Venture Devils.

Anisia’s education has given her the foundation to build one of the first digital navigators in the industry, build Stanford’s Chronic Disease Self-Management programs through the city of San Francisco, build the network of providers for Centene Corporation, and consult for PepsiCo and other self-insured employers building digital health solutions. Anisia has a passion and curiosity for innovative solutions in digital health, transformations of end-to-end customer journeys, and collaborating with stakeholders in the industry to build quality and profitable solutions.

After being diagnosed with Postacute Sequelae of SARS-CoV-2 (Long Covid) during the Alpha variant of the pandemic, Anisia has put all her efforts into learning how to manage and find solutions for her new chronic diseases. The search for finding providers, to treat a chronic condition with no approved treatment, and vendors, to provide supplemental care, is what lead Anisia to began building the first AI driven digital disease management company for chronic diseases that introduces and refers growing, reputable, and vetted healthcare solution companies to consumers, launching as a one-stop-shop for people affected by Long Covid.

In our fragmented market of healthcare services, one may spend hours and thousands of dollars testing multiple solutions to manage their disease. With a condition such as Long Covid, where provider and pharmaceutical treatment have not caught up, Scope is on a mission to provide hope, the highest standard of disease management, and improve on cost transparency and health outcomes. Scoping out Chronic Disease podcast is a way to highlight and understand all the vendor solution products and companies in the industry.